REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nanosanguis S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Engineering Services | Administrative Management and General Management Consulting Services | Marketing Consulting Services | Scientific Research and Development Services
Full name: Nanosanguis S.A. Profile Updated: September 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

nanosanguis, based in Warsaw, Poland, develops red blood cell substitutes for organ transport systems, aiming to provide physiological conditions and the ability for organ regeneration before transplant.

Headquarters
Ul. Rakowiecka 36
Warsaw; Mazowieckie; Postal Code: 02-532

Contact Details: Purchase the Nanosanguis S.A. report to view the information.

Website: http://www.nanosanguis.com

Basic Information
Total Employees:
Purchase the Nanosanguis S.A. report to view the information.
Registered Capital:
Purchase the Nanosanguis S.A. report to view the information.
Financial Auditors:
Purchase the Nanosanguis S.A. report to view the information.
Incorporation Date:
January 12, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Nanosanguis S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
64.58%▲
Total operating revenue
-82.13%▼
Operating profit (EBIT)
-175.96%▼
EBITDA
-177.75%▼
Net Profit (Loss) for the Period
-152.17%▼
Total Assets
36.16%▲
Total Equity
106.06%▲
Operating Profit Margin (ROS)
-2170.62%▼
Net Profit Margin
-1967.63%▼
Return on Equity (ROE)
-3.02%▼
Quick Ratio
1.02%▲
Cash Ratio
0.75%▲

Similar companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
 
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
Pit-Radwar S.A.
 
Naukowa I Akademicka Siec Komputerowa - Panstwowy Instytut Badawczy
"Novo Nordisk Pharma" Sp. z o.o.
 
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
Clinical Research Center Sp. z o.o.
 
Ambioteco Sp. z o.o.
Ai Corelab Sp z oo
 
Map Your Dna Sp. z o.o.
Vitrotest Europe Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo